DUBLIN--(BUSINESS WIRE)--The "Rheumatoid Arthritis Drugs Market by Drug Type and by Distribution Channel: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The report covers a forecast and an analysis of the rheumatoid arthritis drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion).
The study includes drivers and restraints of the rheumatoid arthritis drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the rheumatoid arthritis drugs market on a global level.
In order to give the users of this report a comprehensive view of the rheumatoid arthritis drugs market, we have included a competitive landscape and an analysis of Porter's Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug type, distribution channel, and regional segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new drug type launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the rheumatoid arthritis drugs market based on drug type, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Some leading players of the global rheumatoid arthritis drugs market include Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals, Inc., Johnson & Johnson, Amgen, Inc., UCB S.A., Pfizer, Inc., Bristol-Myers Squibb, AbbVie, F. Hoffmann-La Roche AG, and Novartis International AG.
Key Topics Covered
Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
Chapter 2. Executive Summary
2.1. Global rheumatoid arthritis drugs market, 2016-2025 (USD Billion)
2.2. Global rheumatoid arthritis drugs market: snapshot
Chapter 3. Rheumatoid Arthritis Drugs Market - Industry Dynamics
3.2. Market Drivers
3.2.1. Global rheumatoid arthritis drugs market drivers: impact analysis
3.2.2. The increasing acceptance of large molecules biologics and biosimilars by rheumatologists
3.2.3. Well-defined reimbursement and regulatory framework in developed regions
3.2.4. Improving treatment options for moderate-to-severe rheumatoid arthritis with second-line therapies
3.2.5. Reorientation of treatment approach from the relief of symptoms to targeted therapy to achieve disease remission
3.3. Market Restraints
3.3.1. Global rheumatoid arthritis drugs market restraints: impact analysis
3.3.2. Treatment accessibility
3.3.3. Patent expiration of blockbuster drugs
3.3.4. Alternative treatment options for rheumatoid arthritis
3.4.1. Growth opportunities for companies operating in the market
3.5. Porter's Five Forces Analysis
3.6. Market Attractiveness Analysis
Chapter 4. Global Rheumatoid Arthritis Drugs Market - Competitive Landscape
4.1. Company market share analysis
4.2. Strategic development
4.3. Price trend analysis
Chapter 5. Global Rheumatoid Arthritis Drugs Market - Drug Type Analysis
5.1. Global rheumatoid arthritis drugs market: drug type overview
Chapter 6. Global Rheumatoid Arthritis Drugs Market - Distribution Channel Analysis
6.1. Global rheumatoid arthritis drugs market: distribution channel overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Drug Stores
6.5. Online Sales
Chapter 7. Global Rheumatoid Arthritis Drugs Market - Regional Analysis
7.1. Global rheumatoid arthritis drugs market: regional overview
7.2. North America
7.5. Latin America
7.6. The Middle East and Africa
Chapter 8. Company Profiles
8.1. Boehringer Ingelheim GmbH
8.2. Regeneron Pharmaceuticals, Inc.
8.3. Johnson & Johnson
8.4. Amgen, Inc.
8.5. UCB S.A.
8.6. Pfizer, Inc.
8.7. Bristol-Myers Squibb
8.9. F. Hoffmann-La Roche AG
8.10. Novartis International AG
For more information about this report visit https://www.researchandmarkets.com/r/uc0hi1